Join our community of smart investors

A glaring valuation anomaly exposed

A small-cap investment company's cash pile and listed holdings back up 90 per cent of its share price, meaning its unlisted portfolio is in the price for 90 per cent below carrying value
A glaring valuation anomaly exposed
  • Portfolio company Sofant signs contract with the UK Space Agency and European Space Agency and has successful fundraise.
  • ProAxsis wins US patent for technology associated with a patented bone-specific enzyme-linked immunoassay.

NetScientific (NCSI: 98p), an investment company that backs early-stage life sciences, healthcare, and technology businesses has announced a raft of news for its portfolio companies.

Sofant, the Edinburgh University spin-out that is developing a state-of-the-art antenna for satellite communications and 5G applications, has signed a $7.3m (£5.4m) contract with the UK Space Agency and European Space Agency. It will support the commercialisation of Sofant’s low-cost, low-power satellite communications platform that requires 70 per cent less power by eliminating the need for complex and expensive cooling systems. By connecting devices wirelessly via a satellite network, Sofant’s terminal also reduces the needs for terrestrial infrastructure and makes it easier for people in rural and remote locations to access the internet. Sofant also completed a £843,000 fundraise, of which £300,000 was made by Netscientific.

To continue reading...
Join our Community of Smart Investors
  • Independent full-length company analysis
  • Actionable investment ideas and recommendations
  • Expert investment tools and data
  • Stock screens from Algy Hall
Have an account? Sign in